Epizyme, Inc
EPZM
EPZM was delisted on the 11th of August, 2022.
98 hedge funds and large institutions have $465M invested in Epizyme, Inc in 2015 Q3 according to their latest regulatory filings, with 16 funds opening new positions, 40 increasing their positions, 26 reducing their positions, and 13 closing their positions.
54% more repeat investments, than reductions
Existing positions increased: 40 | Existing positions reduced: 26
23% more first-time investments, than exits
New positions opened: 16 | Existing positions closed: 13
3% more funds holding
Funds holding: 95 → 98 (+3)
0% more funds holding in top 10
Funds holding in top 10: 4 → 4 (0)
28% less call options, than puts
Call options by funds: $3.79M | Put options by funds: $5.25M
44% less capital invested
Capital invested by funds: $825M → $465M (-$359M)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
PAI
Palo Alto Investors
Palo Alto,
California
|
+$41.5M |
| 2 |
Morgan Stanley
New York
|
+$5.89M |
| 3 |
SIM
Spark Investment Management
New York
|
+$4.71M |
| 4 |
RCM
RA Capital Management
Boston,
Massachusetts
|
+$4.58M |
| 5 |
BIT
BlackRock Institutional Trust
San Francisco,
California
|
+$4.14M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Point72 Asset Management
Stamford,
Connecticut
|
-$11.6M |
| 2 |
Allianz Asset Management
Munich,
Germany
|
-$7.46M |
| 3 |
Balyasny Asset Management
Chicago,
Illinois
|
-$4.22M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$4.21M |
| 5 |
EC
EcoR1 Capital
San Francisco,
California
|
-$3.9M |
EPZM Hedge Fund Activity: Q3 2015 in Review
98 of the 3,590 institutional investors tracked by Wall St. Rank reported a position in Epizyme, Inc (EPZM) for Q3 2015, worth a combined $465M — down 44% from $825M a quarter earlier.
Buyers outnumbered sellers: 16 funds opened new EPZM positions and 13 closed out — a net gain of 3 holders — while 40 added to existing stakes and 26 trimmed.
The largest buyer was Palo Alto Investors, adding an estimated $41.5M. The largest seller was Point72 Asset Management, exiting entirely with an estimated $11.6M sold.
- 98 institutional investors held Epizyme, Inc (EPZM) as of Q3 2015, up from 95 in Q2 2015.
- Funds reported $465M of Epizyme, Inc stock for Q3 2015, down 44% quarter-over-quarter.
- 16 funds opened new Epizyme, Inc positions in Q3 2015 and 13 closed out, a net change of +3 holders.
- The largest Epizyme, Inc buyer in Q3 2015 was Palo Alto Investors, an estimated $41.5M added.
- The largest Epizyme, Inc seller in Q3 2015 was Point72 Asset Management, an estimated $11.6M sold.
Based on aggregated 13F filings for Q3 2015.